Literature DB >> 22773924

Quantitative Molecular Imaging of Neuronal Nicotinic Acetylcholine Receptors in the Human Brain with A-85380 Radiotracers.

Shahrdad Lotfipour1, Mark Mandelkern, Arthur L Brody.   

Abstract

Neuronal nicotinic acetylcholine receptors (nAChRs) have been implicated in a spectrum of cognitive functions as well as psychiatric and neurodegenerative disorders, including tobacco addiction and Alzheimer's Disease. The examination of neuronal nAChRs in living humans is a relatively new field. Researchers have developed brain-imaging radiotracers for nAChRs, with radiolabeled A-85380 compounds having the most widespread use. We provide a brief background on nAChRs, followed by a discussion of the development and application of A-85380 radiotracers in human imaging studies. We describe potential future studies using nicotinic receptor radioligands for the study of tobacco addiction, including the mechanism of action of the smoking-cessation therapy varenicline. Throughout this review, we focus on the significant potential that resides in the identification and quantification of nAChRs in the living human brain.

Entities:  

Year:  2011        PMID: 22773924      PMCID: PMC3389797          DOI: 10.2174/157340511795445676

Source DB:  PubMed          Journal:  Curr Med Imaging Rev        ISSN: 1573-4056


  81 in total

1.  In vivo imaging of human cerebral nicotinic acetylcholine receptors with 2-18F-fluoro-A-85380 and PET.

Authors:  Jean-Dominique Gallezot; Michel Bottlaender; Marie-Claude Grégoire; Dimitri Roumenov; Jean-Robert Deverre; Christine Coulon; Michèle Ottaviani; Frédéric Dollé; André Syrota; Héric Valette
Journal:  J Nucl Med       Date:  2005-02       Impact factor: 10.057

Review 2.  Nicotinic receptors in the development and modulation of CNS synapses.

Authors:  L W Role; D K Berg
Journal:  Neuron       Date:  1996-06       Impact factor: 17.173

3.  2-, 5-, and 6-Halo-3-(2(S)-azetidinylmethoxy)pyridines: synthesis, affinity for nicotinic acetylcholine receptors, and molecular modeling.

Authors:  A O Koren; A G Horti; A G Mukhin; D Gündisch; A S Kimes; R F Dannals; E D London
Journal:  J Med Chem       Date:  1998-09-10       Impact factor: 7.446

Review 4.  Modulatory role of presynaptic nicotinic receptors in synaptic and non-synaptic chemical communication in the central nervous system.

Authors:  E S Vizi; B Lendvai
Journal:  Brain Res Brain Res Rev       Date:  1999-11

5.  Whole-body biodistribution, radiation absorbed dose, and brain SPET imaging with [123i]5-i-A-85380 in healthy human subjects.

Authors:  Masahiro Fujita; John P Seibyl; D Bruce Vaupel; Gilles Tamagnan; Michele Early; Sami S Zoghbi; Ronald M Baldwin; Andrew G Horti; Andrei O KoreN; Alexey G Mukhin; Shaukat Khan; Ali Bozkurt; Alane S Kimes; Edythe D London; Robert B Innis
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-02       Impact factor: 9.236

Review 6.  Review of the acetylcholinesterase inhibitor galanthamine.

Authors:  J J Sramek; E J Frackiewicz; N R Cutler
Journal:  Expert Opin Investig Drugs       Date:  2000-10       Impact factor: 6.206

7.  Nicotine therapy in adulthood reverses the synaptic and behavioral deficits elicited by prenatal exposure to phenobarbital.

Authors:  Avital Beer; Theodore A Slotkin; Frederic J Seidler; Justin E Aldridge; Joseph Yanai
Journal:  Neuropsychopharmacology       Date:  2005-01       Impact factor: 7.853

8.  5-Iodo-A-85380, an alpha4beta2 subtype-selective ligand for nicotinic acetylcholine receptors.

Authors:  A G Mukhin; D Gündisch; A G Horti; A O Koren; G Tamagnan; A S Kimes; J Chambers; D B Vaupel; S L King; M R Picciotto; R B Innis; E D London
Journal:  Mol Pharmacol       Date:  2000-03       Impact factor: 4.436

9.  Characterization of bovine and human neuronal nicotinic acetylcholine receptors using monoclonal antibodies.

Authors:  P J Whiting; J M Lindstrom
Journal:  J Neurosci       Date:  1988-09       Impact factor: 6.167

10.  Baseline expression of alpha4beta2* nicotinic acetylcholine receptors predicts motivation to self-administer nicotine.

Authors:  Bernard Le Foll; Svetlana I Chefer; Alane S Kimes; Dean Shumway; Elliot A Stein; Alexey G Mukhin; Steven R Goldberg
Journal:  Biol Psychiatry       Date:  2008-12-18       Impact factor: 13.382

View more
  7 in total

1.  Decreased Nicotinic Receptor Availability in Smokers with Slow Rates of Nicotine Metabolism.

Authors:  Jacob G Dubroff; Robert K Doot; Mary Falcone; Robert A Schnoll; Riju Ray; Rachel F Tyndale; Arthur L Brody; Catherine Hou; Alexander Schmitz; Caryn Lerman
Journal:  J Nucl Med       Date:  2015-08-13       Impact factor: 10.057

2.  Nicotinic α4β2 receptor imaging agents. Part IV. Synthesis and biological evaluation of 3-(2-(S)-3,4-dehydropyrrolinyl methoxy)-5-(3'-¹⁸F-fluoropropyl)pyridine (¹⁸F-Nifrolene) using PET.

Authors:  Rama Pichika; Sharon A Kuruvilla; Narmisha Patel; Kenny Vu; Sangamitra Sinha; Balu Easwaramoorthy; Tanjore K Narayanan; Bingzhi Shi; Bradley Christian; Jogeshwar Mukherjee
Journal:  Nucl Med Biol       Date:  2012-11-07       Impact factor: 2.408

3.  A single administration of low-dose varenicline saturates α4β2* nicotinic acetylcholine receptors in the human brain.

Authors:  Shahrdad Lotfipour; Mark Mandelkern; Miguel Alvarez-Estrada; Arthur L Brody
Journal:  Neuropsychopharmacology       Date:  2012-03-07       Impact factor: 7.853

4.  Nicotine Activating α4β2 Nicotinic Acetylcholine Receptors to Suppress Neuroinflammation via JAK2-STAT3 Signaling Pathway in Ischemic Rats and Inflammatory Cells.

Authors:  Qi Wang; Jinyu Gou; Shenrui Guo; Feng Wei; Tingting Han; Ruihe Lai; Dalong Zhang; Yao Diao; Yafu Yin
Journal:  Mol Neurobiol       Date:  2022-03-17       Impact factor: 5.590

Review 5.  Bidirectional Associations among Nicotine and Tobacco Smoke, NeuroHIV, and Antiretroviral Therapy.

Authors:  Shivesh Ghura; Robert Gross; Kelly Jordan-Sciutto; Jacob Dubroff; Robert Schnoll; Ronald G Collman; Rebecca L Ashare
Journal:  J Neuroimmune Pharmacol       Date:  2019-12-13       Impact factor: 4.147

6.  Cholinergic Pathway SNPs and Postural Control in 477 Older Adults.

Authors:  Carina Arnold; Claudia Schulte; Mariana Moscovich; Ulrike Sünkel; Laura Zaunbrecher; Florian Metzger; Thomas Gasser; Gerhard W Eschweiler; Ann-Kathrin Hauser; Daniela Berg; Walter Maetzler
Journal:  Front Aging Neurosci       Date:  2018-09-04       Impact factor: 5.750

Review 7.  Acetylcholine signaling system in progression of lung cancers.

Authors:  Jamie R Friedman; Stephen D Richbart; Justin C Merritt; Kathleen C Brown; Nicholas A Nolan; Austin T Akers; Jamie K Lau; Zachary R Robateau; Sarah L Miles; Piyali Dasgupta
Journal:  Pharmacol Ther       Date:  2018-10-03       Impact factor: 13.400

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.